Meeting Abstract

Evaluation of cystatin C and NGAL as predictors of mortality in patients undergoing percutaneous mitral valve repair


Authors listDoerr, O.; Walther, C.; Liebetrau, C.; Ortlieb, M.; Lorenz, J.; Moellmann, H.; Gaede, L.; Boeder, N.; Weipert, K. F.; Troidl, C.; Voss, S.; Bauer, T.; Hamm, C.; Nef, H. M.

Publication year2017

Pages267-267

JournalEuropean Heart Journal

Volume number38

ISSN0195-668X

eISSN1522-9645

PublisherOxford University Press



Citation Styles

Harvard Citation styleDoerr, O., Walther, C., Liebetrau, C., Ortlieb, M., Lorenz, J., Moellmann, H., et al. (2017) Evaluation of cystatin C and NGAL as predictors of mortality in patients undergoing percutaneous mitral valve repair, European Heart Journal, 38, p. 267

APA Citation styleDoerr, O., Walther, C., Liebetrau, C., Ortlieb, M., Lorenz, J., Moellmann, H., Gaede, L., Boeder, N., Weipert, K., Troidl, C., Voss, S., Bauer, T., Hamm, C., & Nef, H. (2017). Evaluation of cystatin C and NGAL as predictors of mortality in patients undergoing percutaneous mitral valve repair. European Heart Journal. 38, 267.


Last updated on 2025-03-07 at 08:51